Haemonetics | HAE - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Baxter International USD 2.68B 3.36B 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 4.2B 49M 2026-06
Cerus USD 34.78M 2.98M 2024-12
Cooper Companies USD 1.11B 301.2M 2026-03
Fresenius EUR 5.23B 9M 2026-06
Fresenius Medical Care EUR 4.32B 20.7M 2026-06
Globus Medical USD 835.58M 239.73M 2026-06
Haemonetics USD 145.34M 148.66M 2026-06
ICU Medical USD 491.25M 8.59M 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
Medtronic USD 7.92B 203M 2026-06
Merit Medical Systems USD 358.44M 20.72M 2026-06
Neogen USD 222.2M 7.7M 2026-03
OraSure Technologies USD 40.35M 2.45M 2025-12
Plus Therapeutics USD 8.15M 1.04M 2026-03
Quidel USD 646.2M 1.21B 2026-06
ResMed USD 1.01B 83.57M 2026-06
STAAR Surgical USD 83.43M 7.32M 2026-06
Steris USD 1.21B 62.8M 2026-06
Stryker USD 4.8B 118M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 222.33B 46.54B 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
US Physical Therapy USD 192.11M 6.23M 2026-06
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06